Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 20 13:11 ET · Ratings

Aptose Biosciences Analyst Ratings

BenzingaNov 20 12:59 ET · Ratings

Canada Net Change Percentage Gainers & Losers

Dow JonesNov 20 12:31 ET

Aptose Biosciences Initiates Phase 1/2 Study for Newly Diagnosed Acute Myeloid Leukemia Patients

MT NewswiresNov 20 12:19 ET

Express News | Aptose Biosciences Inc : H.c. Wainwright Cuts Target Price to $2 From $7

ReutersNov 20 09:58 ET

Aptose Biosciences Down 5% in U.S. Premarket, Initiates Study for Newly Diagnosed AML Patients

MT NewswiresNov 20 08:31 ET